Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome.
about
Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune DiseasesEmerging roles for HMGB1 protein in immunity, inflammation, and cancerPrognostic impact of clinical course-specific mRNA expression profiles in the serum of perioperative patients with esophageal cancer in the ICU: a case control study.HMGB1 in health and disease.Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome.Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation.Examination of Setarud (IMOD™) in the management of patients with severe sepsisAssociations between Single Nucleotide Polymorphisms of High Mobility Group Box 1 Protein and Clinical Outcomes in Korean Sepsis Patients.HMGB1 gene polymorphisms in patients with chronic hepatitis B virus infectionYear in review 2008: Critical Care--sepsisRole of high mobility group box 1 in inflammatory disease: focus on sepsis.Fc Gamma Receptor IIA (CD32A) R131 Polymorphism as a Marker of Genetic Susceptibility to Sepsis.High mobility group box-1 protein--one step closer to the clinic?Post-translational modifications of high mobility group box 1 and cancer.Association of single-nucleotide polymorphisms of high-mobility group box 1 with susceptibility and clinicopathological characteristics of uterine cervical neoplasia in Taiwanese women.Association ofHMGB1andHMGB2genetic polymorphisms with lung cancer chemotherapy responseUmbelliferone alleviates hepatic injury in diabetic db/db mice via inhibiting inflammatory response and activating Nrf2-mediated antioxidant
P2860
Q26768480-73868F0B-0728-47E1-8670-10F3438DEE5AQ27015835-341FAE3A-BCFA-4D2C-BCEE-168B68406EC8Q34321550-306420A6-44AF-4046-9CA0-8AB7D1BD8C3DQ34622835-B210430F-741E-4721-8855-5555B844A712Q34988829-77A7C5B1-D399-402D-A404-37171A3D7F31Q35183879-BB7AA137-4D89-4515-BD65-2B941C1D2384Q35596480-AB53120B-9921-4409-81A2-B89C6505ECADQ36418658-062F8E35-1176-434F-9782-411555C925CDQ37102492-39BF9CF9-0843-44E7-8EF9-BDAD934BB669Q37626881-D9F96556-C7B7-4A27-9974-474774E8E6ADQ38051217-49452719-95BA-48C4-BCFF-7C28484EADAFQ40404277-159FDFB3-0F98-44CB-9B93-98F9B79FFC92Q43249094-4D4D2585-D9AB-4CB0-8134-52BD5E3E1940Q47220872-A46565BF-97D3-45AE-B575-EFB3E979BAE1Q51430290-D14A5358-CBFB-46E3-A236-0112A672BA13Q57500224-A845420C-A1A0-4E8E-A094-50AE67017FABQ58693556-98F1C02D-D05D-49C1-A66B-D5E96A7ED1A0
P2860
Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Association of HMGB1 polymorph ...... nflammatory response syndrome.
@en
type
label
Association of HMGB1 polymorph ...... nflammatory response syndrome.
@en
prefLabel
Association of HMGB1 polymorph ...... nflammatory response syndrome.
@en
P2093
P2860
P356
P1433
P1476
Association of HMGB1 polymorph ...... nflammatory response syndrome.
@en
P2093
Brian Kornblit
Hans O Madsen
Jens Strøm
Lars Vindeløv
Lea Munthe-Fog
P2860
P2888
P356
10.1186/CC6935
P50
P577
2008-06-24T00:00:00Z
P5875
P6179
1047543311